102 related articles for article (PubMed ID: 31452783)
1. Establishment and characterization of the gemcitabine-resistant human pancreatic cancer cell line SW1990/gemcitabine.
Yu Y; Ding F; Gao M; Jia YF; Ren L
Oncol Lett; 2019 Sep; 18(3):3065-3071. PubMed ID: 31452783
[TBL] [Abstract][Full Text] [Related]
2. [Establish a gemcitabine-resistant pancreatic cancer cell line SW1990/GZ and research the relationship between SW1990/GZ and pancreatic cancer stem cell].
An Y; Yao J; Wei JS; Lu ZP; Cai HH; Dai CC; Qian ZY; Xu ZK; Miao Y
Zhonghua Wai Ke Za Zhi; 2010 Jul; 48(13):999-1003. PubMed ID: 21054984
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-429 sensitizes pancreatic cancer cells to gemcitabine through regulation of PDCD4.
Yu G; Jia B; Cheng Y; Zhou L; Qian B; Liu Z; Wang Y
Am J Transl Res; 2017; 9(11):5048-5055. PubMed ID: 29218103
[TBL] [Abstract][Full Text] [Related]
4. Emodin potentiates the antitumor effects of gemcitabine in pancreatic cancer cells via inhibition of nuclear factor-κB.
Liu A; Chen H; Tong H; Ye S; Qiu M; Wang Z; Tan W; Liu J; Lin S
Mol Med Rep; 2011; 4(2):221-7. PubMed ID: 21468555
[TBL] [Abstract][Full Text] [Related]
5. Induction of pancreatic cancer cell apoptosis, invasion, migration, and enhancement of chemotherapy sensitivity of gemcitabine, 5-FU, and oxaliplatin by hnRNP A2/B1 siRNA.
Gu WJ; Liu HL
Anticancer Drugs; 2013 Jul; 24(6):566-76. PubMed ID: 23525071
[TBL] [Abstract][Full Text] [Related]
6. [Drug resistance and activity changes of thioredoxin reductase in pancreatic cancer cells strain SW1990 induced by gemcitabine].
Niu BZ; Chen G; Li LJ; Wu YD; Zhao YP
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Oct; 27(5):606-10. PubMed ID: 16274042
[TBL] [Abstract][Full Text] [Related]
7. [A pilot study on the impact of the drug resistance on the radioresistance in human pancreatic cancer cell lines].
Chen G; Zhao YP; Jiang H; Guo JC; Zhang LY; Niu BZ; Wu WW
Zhonghua Wai Ke Za Zhi; 2006 Jul; 44(13):921-3. PubMed ID: 17067488
[TBL] [Abstract][Full Text] [Related]
8. Emodin reverses resistance to gemcitabine in pancreatic cancer by suppressing stemness through regulation of the epithelial‑mesenchymal transition.
Wei W; Wang J; Hu Y; Chen S; Liu J
Exp Ther Med; 2023 Jan; 25(1):7. PubMed ID: 36545274
[TBL] [Abstract][Full Text] [Related]
9. Microarray analysis of circular RNA expression profiles associated with gemcitabine resistance in pancreatic cancer cells.
Xu C; Yu Y; Ding F
Oncol Rep; 2018 Jul; 40(1):395-404. PubMed ID: 29781033
[TBL] [Abstract][Full Text] [Related]
10. Expression and promoter methylation analysis of ATP-binding cassette genes in pancreatic cancer.
Chen M; Xue X; Wang F; An Y; Tang D; Xu Y; Wang H; Yuan Z; Gao W; Wei J; Zhang J; Miao Y
Oncol Rep; 2012 Jan; 27(1):265-9. PubMed ID: 21956451
[TBL] [Abstract][Full Text] [Related]
11. MiR-199 Reverses the Resistance to Gemcitabine in Pancreatic Cancer by Suppressing Stemness through Regulating the Epithelial-Mesenchymal Transition.
Wei W; Wang L; Xu L; Liang J; Teng L
ACS Omega; 2021 Nov; 6(47):31435-31446. PubMed ID: 34869970
[TBL] [Abstract][Full Text] [Related]
12. Genomic analysis of drug resistant pancreatic cancer cell line by combining long non-coding RNA and mRNA expression profling.
Zhou M; Ye Z; Gu Y; Tian B; Wu B; Li J
Int J Clin Exp Pathol; 2015; 8(1):38-52. PubMed ID: 25755691
[TBL] [Abstract][Full Text] [Related]
13. [Establishment, characterization, and biological analysis of pancreatic adenocarcinoma cell strain SW1990/FU].
Guo JC; Zhao YP; Liao Q; Chen G; Zhang LY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Oct; 27(5):592-6. PubMed ID: 16274039
[TBL] [Abstract][Full Text] [Related]
14. [Down regulation of mitogen activated protein kinase phosphatase-1 mediate acquired multidrug resistance in pancreatic adenocarcinoma cell line SW1990/Fu].
Guo JC; Zhao YP; Liao Q; Chen G; Zhu Y
Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):473-5. PubMed ID: 16772084
[TBL] [Abstract][Full Text] [Related]
15. [Expression and significance of GCS gene in human pancreatic cancer cell SW1990 and its drug-resistant sublines].
Bu GB; Zhao YP; Chen G; Zhang TP; Li LJ; Wu YD
Zhonghua Wai Ke Za Zhi; 2006 Oct; 44(19):1342-4. PubMed ID: 17217822
[TBL] [Abstract][Full Text] [Related]
16. Oridonin overcomes the gemcitabine resistant PANC-1/Gem cells by regulating GST pi and LRP/1 ERK/JNK signalling.
Wang B; Shen C; Li Y; Zhang T; Huang H; Ren J; Hu Z; Xu J; Xu B
Onco Targets Ther; 2019; 12():5751-5765. PubMed ID: 31410021
[No Abstract] [Full Text] [Related]
17. Nardoguaianone L Isolated from
Zheng YD; Ma LM; Lu JJ; Chai T; Naghavi MR; Ma JY; Sang CY; Yang JL
Molecules; 2022 Oct; 27(20):. PubMed ID: 36296442
[TBL] [Abstract][Full Text] [Related]
18. Epithelial mesenchymal transition correlates with CD24+CD44+ and CD133+ cells in pancreatic cancer.
Zhang Y; Wei J; Wang H; Xue X; An Y; Tang D; Yuan Z; Wang F; Wu J; Zhang J; Miao Y
Oncol Rep; 2012 May; 27(5):1599-605. PubMed ID: 22322379
[TBL] [Abstract][Full Text] [Related]
19. Hyperthermia enhances the sensitivity of pancreatic cancer SW1990 cells to gemcitabine through ROS/JNK signaling.
Jin H; Zhao Y; Yang J; Zhang X; Ma S
Oncol Lett; 2018 Nov; 16(5):6742-6748. PubMed ID: 30405817
[TBL] [Abstract][Full Text] [Related]
20. Microarray analysis of gene expression profile of multidrug resistance in pancreatic cancer.
Zhao YP; Chen G; Feng B; Zhang TP; Ma EL; Wu YD
Chin Med J (Engl); 2007 Oct; 120(20):1743-52. PubMed ID: 18028764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
